Researchers at the University of Utah Health in Salt Lake City examined endoscopes used in 50 outpatient colonoscopies and 55 esophagogastroduodenoscopy procedures, or EGD tests. The latter procedure allows clinicians to examine the inside of a patient’s esophagus, stomach and duodenum.
Researchers found retained biopsy samples in the endoscopes after 64 percent of all procedures. Recovered tissue was sent to pathology for evaluation, which changed or added to the diagnosis of five patients.
“All of these changes were minor, and patients were already on appropriate treatment,” said study author Gregory Toy, MD, an internal medicine resident at University of Utah Health, according to Medscape. “The take-home message would be that retained biopsies are much more common than most endoscopists would think.”
The findings also highlight the importance of diligent endoscope reprocessing between procedures, according to Serge Sorser, MD, a gastroenterologist at Ascension Michigan Providence Hospital in Novi who was not involved in the study.
Dr. Toy presented the research May 31 at the American Gastroenterological Association’s Digestive Diseases Week in San Diego, Calif.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
